Vapotherm’s revolutionary high-velocity therapy has been proven to be non-inferior to nCPAP in neonates and NIV in adults, even with hypercapnic respiratory failure. Due to the high velocity of oxygen flow through Vapotherm’s small-bore cannula, deadspace is reduced and alveolar ventilation increases.

Oxygen Assist is a module that is a closed-loop controller that titrates FiO2 based on the patient’s SpO2 while on Vapotherm’s Precision Flow. Perfect for reducing nursing workload while increasing time in target SpO2 for fragile premature babies.